Loi and coworkers showed in a TNBC mouse model that blocking the Ras/MAPK signaling pathway diminished the number of tumor-infiltrating T lymphocytes (TILs) and increased MHC and PD-L1 expression (Loi et al. 2016). The gene discussed is CD274; the disease is neoplasm.